- Home
- PRPO vs IBG Comparison
PRPO vs IBG Comparison
Compare PRPO & IBG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPO
- IBG
- Stock Information
- Founded
- PRPO N/A
- IBG 2018
- Country
- PRPO United States
- IBG Australia
- Employees
- PRPO N/A
- IBG N/A
- Industry
- PRPO Biotechnology: Laboratory Analytical Instruments
- IBG Beverages (Production/Distribution)
- Sector
- PRPO Industrials
- IBG Consumer Staples
- Exchange
- PRPO Nasdaq
- IBG Nasdaq
- Market Cap
- PRPO 8.8M
- IBG 9.6M
- IPO Year
- PRPO N/A
- IBG 2024
- Fundamental
- Price
- PRPO $5.79
- IBG $1.11
- Analyst Decision
- PRPO
- IBG Strong Buy
- Analyst Count
- PRPO 0
- IBG 1
- Target Price
- PRPO N/A
- IBG N/A
- AVG Volume (30 Days)
- PRPO 5.7K
- IBG 1.0M
- Earning Date
- PRPO 11-06-2024
- IBG 02-15-2025
- Dividend Yield
- PRPO N/A
- IBG N/A
- EPS Growth
- PRPO N/A
- IBG N/A
- EPS
- PRPO N/A
- IBG N/A
- Revenue
- PRPO $17,411,000.00
- IBG $3,147,763.00
- Revenue This Year
- PRPO $75.18
- IBG N/A
- Revenue Next Year
- PRPO N/A
- IBG N/A
- P/E Ratio
- PRPO N/A
- IBG N/A
- Revenue Growth
- PRPO 31.31
- IBG N/A
- 52 Week Low
- PRPO $4.31
- IBG $0.60
- 52 Week High
- PRPO $7.30
- IBG $3.35
- Technical
- Relative Strength Index (RSI)
- PRPO 41.19
- IBG N/A
- Support Level
- PRPO $5.72
- IBG N/A
- Resistance Level
- PRPO $6.48
- IBG N/A
- Average True Range (ATR)
- PRPO 0.24
- IBG 0.00
- MACD
- PRPO 0.01
- IBG 0.00
- Stochastic Oscillator
- PRPO 0.00
- IBG 0.00
About PRPO Precipio Inc.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
About IBG Innovation Beverage Group Limited Ordinary Shares
Innovation Beverage Group Ltd is a developer, manufacturer, marketer, exporter and retailer of a growing beverage portfolio of 60 formulations across 13 alcoholic and non-alcoholic brands. The company's focus is on premium and super premium brands.